Biocytogen Email Format
Biotechnology ResearchMassachusetts, United States201-500 Employees
Biocytogen is a biotechnology research company that provides integrated solutions for developing next-generation antibody drugs. Powered by advanced gene editing technologies and a state-of-the-art animal facility, it maintains a platform for efficient antibody discovery and validation, including animal model generation and in vivo and in vitro preclinical studies. The company’s therapeutic antibody discovery leverages RenMab mice. Biocytogen collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide. Headquartered in Waltham, Massachusetts, Biocytogen employs between 201 and 500 people.